Abstract:Level IB metastasis is relatively rare in nasopharyngeal carcinoma (NPC). However, many institutions recommend electively irradiation to level IB to level V in NPC, which covers the submandibular glands (SMG) in the target volume and is associated with deterioration of xerostomia. The purpose of this study is to investigate the high-risk factors for level IB metastasis in NPC and evaluate the feasibility of selectively omission of radiation to level IB in the low-risk subgroups. This retrospective study identified 532 patients with non-metastatic NPC treated by intensity modulated radiation therapy (IMRT) in our institution from 2009 to 2010. Level IB nodes were electively included in the clinical target volume based on the attending physician’s decision. At that time, the SMG dose was not constrained during inverse treatment planning. Late xerostomia was scored according to CTCAE 3.0 system. Diagnostic head and neck MRIs were retrospectively reviewed and the involvement of nodal levels was evaluated according to RTOG guidelines. The correlation of level IB metastasis and other imaging factors were studied using Chi-square test and logistic regression model. Log-rank test was used to compare survival rates. Cox proportional-hazards models were used to evaluate the effect of various factors on survival. Univariate analysis showed that advanced N stage, bilateral nodal metastasis, level IIA involvement, the maximal axial diameter (MAD) of level IIA nodes >20 mm, necrosis or extracapsular spread of level IIA correlated with level IB metastasis at diagnosis. In multivariate analysis (MVA), bilateral nodal involvement, MAD of level IIA nodes >20 mm or extracapsular spread of level IIA nodes, were independent predictive factors of level IB metastasis at diagnosis. Patients without either of these factors were denoted low-risk subgroup and the rest high-risk subgroup. With a median follow-up of 51.5 (1.0-74.7) months, the 5-year estimated regional control and overall survival (OS) was 94.4% and 84.8%, respectively. Of the low-risk subgroup, there was no significant difference of regional control and OS between those with or without elective irradiation to level IB. The percentage of level IB recurrence of those without elective irradiation was only 0.46%. Elective level IB irradiation was not significant upon MVA both for regional control and OS. Of the high-risk subgroup, elective level IB irradiation was marginal significant for regional control, but not for OS upon MVA. Overall, elective irradiation of level IB increased the mean doses of SMGs, but did not transfer into reduction of late xerostomia. Our study demonstrated the MAD of level IIA nodes > 20 mm and/or level IIA nodes with extracapsular spread, positive bilateral cervical lymph nodes were independent risk factor for level IB metastasis in NPC. For patients without either of these factors, selectively omission of irradiation to level IB did not impair regional control and OS.

Evaluating the Rationality of the International Guideline's Recommendations Regarding Selective Coverage of Level Ib in Node Clinical Target Volume with Nasopharyngeal Carcinoma: Results from a Real-World Series.

Rationality of the international guideline’s recommendation regarding selective coverage of level Ib in clinical target volume with nasopharyngeal carcinoma: Results from a real-world series

Level Ib sparing intensity-modulated radiation therapy in selected nasopharyngeal carcinoma patients based on the International Guideline

The feasibility of level Ib-sparing intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma and high-risk factors classified based on the International Guideline

Sparing Level Ib Lymph Nodes by Intensity-Modulated Radiotherapy in the Treatment of Nasopharyngeal Carcinoma

Selectively sparing of the supraclavicular area during intensity-modulated radiotherapy in nasopharyngeal carcinoma: A double-center observation study

The Feasibility of Selectively Omission of Radiation to Level IB Lymph Nodes in Low-Risk Nasopharyngeal Carcinoma

Neck level Ib-sparing versus level Ib-irradiation in intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma with high-risk factors: A propensity score-matched cohort study

The Feasibility Analysis of Omission of Elective Irradiation to Level IB Lymph Nodes in Low-Risk Nasopharyngeal Carcinoma Based on the 2013 Updated Consensus Guideline for Neck Nodal Levels

Superficial Parotid Lobe-Sparing Delineation Approach: A Better Method Of Dose Optimization To Protect The Parotid Gland In Intensity-Modulated Radiotherapy For Nasopharyngeal Carcinoma

Level Ib CTV delineation in nasopharyngeal carcinoma based on lymph node distribution and topographic anatomy

Prioritizing Sufficient Dose to Gross Tumor Volume over Normal Tissue Sparing in Intensity-Modulated Radiotherapy Treatment of T4 Nasopharyngeal Carcinoma.

Is a high-risk clinical target volume required? Evaluation of the dosimetric feasibility based on T staging

Long-term results of phase II trial of reduced modified clinical target volume in low-risk nasopharyngeal carcinoma treated with intensity modulated radiotherapy

International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma

Risk factors to identify the indication for regional nodal irradiation in T1-2N1M0 breast cancer: A joint analysis of 4,243 real-world cases from two institutions

Evaluation of risk-tailored individualized selection of radiation therapy target volume for head and neck carcinoma of unknown primary

Analysis of Clinical Target Volume Delineation in Local-regional Failure of Nasopharyngeal Carcinoma after Intensity-modulated Radiotherapy.

Involved site radiation therapy in stage I-III nasopharyngeal carcinoma with limited lymph node burden (ISRT-NPC) or elective region irradiation: a study protocol for a multicenter non-inferiority randomized controlled phase III clinical trial

Four-Year Outcome after Reduction of the Target Volume of Intensity Modulated Radiotherapy Following Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase III, Multicentre, Randomised Controlled Trial

Analysis of Computed Tomography Based Distribution of Metastatic Cervical Nodes in 218 Cases of Nasopharyngeal Carcinoma